scispace - formally typeset
A

Ar Kar Aung

Researcher at Monash University

Publications -  56
Citations -  736

Ar Kar Aung is an academic researcher from Monash University. The author has contributed to research in topics: Medicine & Adverse drug reaction. The author has an hindex of 14, co-authored 49 publications receiving 525 citations. Previous affiliations of Ar Kar Aung include Northern Health & Sir Charles Gairdner Hospital.

Papers
More filters
Journal ArticleDOI

Rickettsial infections in Southeast Asia: implications for local populace and febrile returned travelers.

TL;DR: Challenges in laboratory diagnosis and management aspects of rickettsial infections unique to Southeast Asia are discussed, and data on emerging resistance to antimicrobial drugs and treatment/prevention options are also reviewed.
Journal ArticleDOI

Pulmonary sporotrichosis: case series and systematic analysis of literature on clinico-radiological patterns and management outcomes

TL;DR: Medical therapy alone is likely sufficient for non-cavitary disease while early surgery should be considered for cavitary primary pulmonary sporotrichosis, according to a comprehensive literature review of treatment outcomes based on clinico-radiological presentation patterns of the disease.
Journal ArticleDOI

Old but not forgotten: Antibiotic allergies in General Medicine (the AGM Study).

TL;DR: To determine the nature, prevalence and description accuracy of recorded antibiotic allergy labels (AALs) in a cohort of general medical inpatients, and to assess the feasibility of an oral antibiotic re‐challenge study.
Journal ArticleDOI

Travel risk assessment, advice and vaccinations in immunocompromised travellers (HIV, solid organ transplant and haematopoeitic stem cell transplant recipients): A review

TL;DR: A framework of understanding and approach to aforementioned groups of immunocompromised travellers regarding pre-travel risk assessment and management; in particular travel vaccinations, infectious and non-infectious disease risks and provision of condition-specific advice are provided to reduce travel-related mortality and morbidity.